Jafron Biomedical Announces Global Advisory Board
ZHUHAI, China, June 21, 2021 (GLOBE NEWSWIRE) -- Jafron Biomedical, a pioneer in the blood purification industry, announced it's founding the Global Advisory Board, which includes the worlds top medical experts in clinical research and critical care medicine.
- ZHUHAI, China, June 21, 2021 (GLOBE NEWSWIRE) -- Jafron Biomedical, a pioneer in the blood purification industry, announced it's founding the Global Advisory Board, which includes the worlds top medical experts in clinical research and critical care medicine.
- Their international leadership, extensive clinical expertise will be invaluable in the future development of Jafron, stated Mr. Dong Fan, Founder and Chairman of Jafron.
- About Jafron: Jafron Biomedical is an A-shared GEM listed corporation established in 1989.
- With the support of its new Global Advisory Board, Jafron strives to contribute the global medical community with more extensive research and guidance in blood purification and its cutting-edge technology.